EarningsQ3 2024 Earnings Report

Supernus Pharmaceuticals (S49) Q3 2024 Earnings Report

1 Followers

CH:S49 Q3 2024 EPS Results

Actual EPSCHF0.96

Consensus EPSCHF0.36

Beat/MissBeat by +CHF0.60

One Year Ago EPS-CHF0.24

Actual RevenueCHF144.74M

Expected RevenueCHF129.63M

Beat/MissBeat by +CHF15.11M

YoY Revenue Growth+14.17%

QuarterQ3 2024

Date11/04/2024

TimeAfter Close

Conference CallMonday, November 4, 2024

CH:S49 Upcoming Earnings

Supernus Pharmaceuticals's next earnings date is estimated for March 2, 2027, based on past reporting schedules.

CH:S49 Q3 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 02, 2027	2026 (Q4)	0.85 / -	0.697	―
Oct 29, 2026	2026 (Q3)	0.40 / 0.76	0.828	-8.26% (-0.07)
Aug 03, 2026	2026 (Q2)	0.35 / 0.43	0.748	-42.07% (-0.31)
May 05, 2026	2026 (Q1)	0.25 / 0.50	0.361	37.44% (+0.14)
Feb 24, 2026	2025 (Q4)	0.28 / 0.70	0.615	13.40% (+0.08)
Nov 04, 2025	2025 (Q3)	0.49 / 0.83	0.962	-13.96% (-0.13)
Aug 05, 2025	2025 (Q2)	0.39 / 0.75	0.635	17.77% (+0.11)
May 06, 2025	2025 (Q1)	0.31 / 0.36	0.379	-4.78% (-0.02)
Feb 25, 2025	2024 (Q4)	0.43 / 0.61	0.727	-15.52% (-0.11)
Nov 04, 2024	2024 (Q3)	0.36 / 0.96	-0.239	502.76% (+1.20)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed